USPSTF Screening Intervals

Diabetes

• Screening for new DM2:
  • All adults age 35+
  • Rescreen every 3 years if results are normal
  • Abnormal result on one of three tests (if asx, must repeat test for confirmation or have 2 abnormal tests):
    • Fasting glucose >= 126
    • 2h Oral Glucose Tolerance Test (OGTT) >= 200
    • A1c >= 6.5%
  • OR a single random plasma glucose >200 mg/dL WITH symptomatic hyperglycemia (e.g., polyuria, polydipsia) is diagnostic of diabetes and does not require further confirmatory testing.

Malignancy

• Breast cancer:
  • Biennial screening mammography for women aged 50 to 74 years
• Colorectal cancer (Guidline):
  • All adults 50-75 should be screened for colorectal cancer w/ colonoscopy or FIT testing (Grade A)
  • Consider screening for ages 45-50 as well (Grade B)

• Lung cancer

• Cervical cancer
  • Age 21-29: every 3 years with cervical cytology alone
  • Age 30-65: screening every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology (cotesting)

• Prostate cancer

Cardiovascular Disease

• Abdominal Aortic Aneurysm
  • 1-time screening for abdominal aortic aneurysm (AAA) with ultrasonography in men aged 65 to 75 years who have ever smoked
  • Do not screen asymptomatic women for AAA.

Metabolic Disease

• Osteoporosis:
  • Start age 65 yearsAverage-risk postmenopausal women with BMD measurement